Prof. Dr. Abdullah Sakin

Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder

Van Yüzüncü Yıl University Academic Data Management System, 2020

Kaynak: OpenAlex

Adrenocortical Carcinoma:Single Center Experience

Van Yüzüncü Yıl University Academic Data Management System, 2020

Kaynak: OpenAlex

PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

AYBU AVESIS, 2020

Kaynak: OpenAlex

The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer

Oncology Research and Treatment, 2019

DOI 10.1159/000501595 PMID 31336378 24 atıf (Europe PMC) Kaynak: OpenAlex

Germline Mutations in BRCA1 and BRCA2 in Breast Cancer Patients with High Genetic Risk in Turkish Population

International Journal of Breast Cancer, 2019

DOI 10.1155/2019/9645147 PMID 30713775 18 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

Scientific Reports, 2019

DOI 10.1038/s41598-019-40589-4 PMID 30850724 16 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?

Supportive Care in Cancer, 2019

DOI 10.1007/s00520-019-05055-x PMID 31471631 15 atıf (Europe PMC) Kaynak: OpenAlex

The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer

Pulmonology, 2019

DOI 10.1016/j.pulmoe.2019.11.007 PMID 31839507 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

Oncology Research and Treatment, 2019

DOI 10.1159/000502120 PMID 31437835 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy

Current Problems in Cancer, 2019

DOI 10.1016/j.currproblcancer.2019.05.007 PMID 31200961 12 atıf (Europe PMC) Kaynak: OpenAlex

The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

Journal of Cancer Research and Therapeutics, 2019

DOI 10.4103/jcrt.jcrt_326_18 PMID 33380674 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer

Asian Pacific Journal of Cancer Prevention, 2019

DOI 10.31557/apjcp.2019.20.6.1879 PMID 31244313 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis

The Breast Journal, 2019

DOI 10.1111/tbj.13647 PMID 31562662 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

Lung Cancer, 2019

DOI 10.1016/j.lungcan.2019.05.007 PMID 31200825 4 atıf (Europe PMC) Kaynak: OpenAlex

Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder

Irish Journal of Medical Science (1971 -), 2019

DOI 10.1007/s11845-019-02074-9 PMID 31463895 1 atıf (Europe PMC) Kaynak: OpenAlex

Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors

Journal of Surgical Research, 2019

DOI 10.1016/j.jss.2019.03.059 PMID 31026795 4 atıf (Europe PMC) Kaynak: OpenAlex

Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

PubMed, 2019

PMID 31786840 5 atıf (Europe PMC) Kaynak: OpenAlex

A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).

PubMed, 2019

PMID 30941962 4 atıf (Europe PMC) Kaynak: OpenAlex

The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

Journal of Oncological Sciences, 2019

DOI 10.1016/j.jons.2019.08.003 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

Journal of Oncology Pharmacy Practice, 2019

DOI 10.1177/1078155219865008 PMID 31366267 3 atıf (Europe PMC) Kaynak: OpenAlex

The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer

The European Research Journal, 2019

DOI 10.18621/eurj.470881 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

PubMed, 2019

PMID 31424664 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Non-urothelial Bladder Cancers: Single Center Experience

European Archives of Medical Research, 2019

DOI 10.4274/eamr.galenos.2019.21931 Açık erişimli tam metinKaynak: OpenAlex

P1.14-01 Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

Journal of Thoracic Oncology, 2019

DOI 10.1016/j.jtho.2019.08.1152 Açık erişimli tam metinKaynak: OpenAlex

P2.01-64 Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology, 2019

DOI 10.1016/j.jtho.2019.08.1407 Açık erişimli tam metinKaynak: OpenAlex

Adrenocortical Carcinoma: Single Center Experience

European Archives of Medical Research, 2019

DOI 10.4274/eamr.25744 Açık erişimli tam metinKaynak: OpenAlex

Metastatik Pankreas Kanserinde 2.Basamak Tedavide Kombinasyon Tedavisi Alamayan Hastalarda Tek Ajan Gemsitabin ve Kapesitabin Etkinliğinin Karşılaştırılması

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

KLİNİK ÇALIŞMALARLA ONKOLOJİDE HEDEFLİ TEDAVİLER

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

Metastatik Skuamöz hücreli Akciğer kanserinde Kemoterapi seçenekleri

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

A retrospective analysis on first-line bevacizumab, cetuximab, and panitumumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG)

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

Renal hücreli karsinom tanılı hastalarda nefrektomi esnasında lenf nodu disseksiyonu gerekli midir?

Van Yüzüncü Yıl University Academic Data Management System, 2019

Kaynak: OpenAlex

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Cancer Chemotherapy and Pharmacology, 2018

DOI 10.1007/s00280-018-3713-6 PMID 30374523 13 atıf (Europe PMC) Kaynak: OpenAlex

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

Cancer Chemotherapy and Pharmacology, 2018

DOI 10.1007/s00280-018-3712-7 PMID 30377778 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience

Asian Pacific Journal of Cancer Prevention, 2018

DOI 10.31557/apjcp.2018.19.12.3597 PMID 30583688 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder

Oncology Research and Treatment, 2018

DOI 10.1159/000486598 PMID 29558755 2 atıf (Europe PMC) Kaynak: OpenAlex

Prognostic significance of primary tumor localization in stage II and III colon cancer

World Journal of Gastrointestinal Oncology, 2018

DOI 10.4251/wjgo.v10.i11.410 PMID 30487952 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease

The Medical Journal of Okmeydani Training and Research Hospital, 2018

DOI 10.5222/otd.2018.71224 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer

Journal of Cancer Research and Therapeutics, 2018

DOI 10.4103/jcrt.jcrt_911_17 PMID 32930124 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Annals of Oncology, 2018

DOI 10.1093/annonc/mdy272.315 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.15_suppl.e13000 Kaynak: OpenAlex

P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Journal of Thoracic Oncology, 2018

DOI 10.1016/j.jtho.2018.08.601 Açık erişimli tam metinKaynak: OpenAlex

The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

Annals of Oncology, 2018

DOI 10.1093/annonc/mdy292.023 Açık erişimli tam metinKaynak: OpenAlex

Opere erken evre kolon kanserinde vücut kitle indeksinin nüks lokalizasyonu, hastalıksız sağkalım ve genel sağkalım etkisi

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex

Türkiye’de Metastatik Meme Kanserinde HER2 hedefli tedavide Pertuzumab kullanımı erken dönem güvenlilik verileri

Kocaeli Üniversitesi - AVESİS, 2018

Kaynak: OpenAlex

Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex

Erken evre(1-3) kolon kanseri hastalarında tümör lokalizasyonunun hastalıksı sağkalım ve genel sağkalıma etkisi:tek merkez deneyimi

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex

Hormon pozitif metastatik meme kanseri tedavisinde Fulvestrant etkinlik ve tolerabilitesi

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex

The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex

Metastatik Meme Kanserinde Ne Durumdayız?

Van Yüzüncü Yıl University Academic Data Management System, 2018

Kaynak: OpenAlex